NDC 0078-0415-61 - Zortress
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0078-0415
- Requested NDC
- 0078-0415-61
- Package NDCs from labels
- 0078-0415-61, 0078-0415-20
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Effective date
- 2026-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zortress - Novartis Pharmaceuticals Corporation | Novartis Pharmaceuticals Corporation | 2026-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0078-0415-20 | Zortress | 60 in 1 BOX | TABLET | 60 | 29 | |
| 0078-0415-61 | Zortress | 1 in 1 BLISTER PACK | TABLET | 1 | 29 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0078-0415-20 | EA - Each | 0078-0415 | 9b348836-5677-4a25-be9a-3ea309aa7c9f | 1 | 2012-07-24 |
| 0078-0415-61 | EA - Each | 0078-0415 | 95bd72e5-4c30-436b-b59d-1e3607497c7b | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| EVEROLIMUS | ACTIVE INGREDIENT | 9HW64Q8G6G | ZORTRESS (EVEROLIMUS) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 13 | |
| EVEROLIMUS | ACTIVE MOIETY | 9HW64Q8G6G | ZORTRESS (EVEROLIMUS) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 13 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | ZORTRESS (EVEROLIMUS) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 13 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | ZORTRESS (EVEROLIMUS) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 13 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ZORTRESS (EVEROLIMUS) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 13 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ZORTRESS (EVEROLIMUS) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 13 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ZORTRESS (EVEROLIMUS) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 13 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ZORTRESS (EVEROLIMUS) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | 3NXW29V3WO |
| everolimus | EVEROLIMUS | Aurobindo Pharma Limited | 43ef3c29-0e25-4fdd-aea1-06a20af9bbab | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | 2056895 977427 977434 977438 9HW64Q8G6G |
| Everolimus | EVEROLIMUS | Par Health USA, LLC | 59cb86d5-8706-4619-b074-af253d3e0b68 | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | 2056895 977427 977434 977438 9HW64Q8G6G |
| Everolimus | EVEROLIMUS | Hikma Pharmaceuticals USA Inc. | cf2dd54b-7a1d-4401-9a01-75e68235e433 | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | 9HW64Q8G6G |
| Everolimus | EVEROLIMUS | ANI Pharmaceuticals, Inc. | ed7f01b0-3660-4785-a057-a32eea78d64b | 2026-09-24 | Warnings, Adverse reactions | 9HW64Q8G6G |
| Zortress | EVEROLIMUS | Novartis Pharmaceuticals Corporation | e082a024-7850-400b-a5c2-2a140612562a | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | NDA021560 0078-0415-20 0078-0417-20 0078-0414-61 0078-0415-61 0078-0422-20 0078-0422-61 0078-0414-20 0078-0417-61 0078-0414 0078-0417 0078-0422 0078-0415 00078041561 977440 2056895 2056897 977436 977427 977434 977438 977431 ade28559-5fac-4dfd-a56c-c453ceb9e30b e082a024-7850-400b-a5c2-2a140612562a 9HW64Q8G6G |
| Rohto All-In-One | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE, ZINC SULFATE | The Mentholatum Company | 43e690e4-b381-46e3-838c-33aef5bdadde | 2026-08-20 | Warnings | 3NXW29V3WO |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | 3NXW29V3WO |
| Everolimus | EVEROLIMUS | Hikma Pharmaceuticals USA Inc. | 5aaf2fb7-93f6-40d6-941a-9583a3794ce7 | 2026-08-14 | Warnings, Adverse reactions | 9HW64Q8G6G |
| Dr. Shitong Photon Energy Eye Care Liquid | TETRAHYDROZOLINE HCL 0.05% HYPROMELLOSE 0.3% DR. SHITONG PHOTON ENERGY EYE CARE LIQUID | Wenzhou Yuyuan Pharmaceutical Co., Ltd. | 58ace434-55ef-17ef-e063-6294a90aa878 | 2026-08-10 | Warnings | 3NXW29V3WO |
| Everolimus | EVEROLIMUS | i3 Pharmaceuticals, LLC | be5da0fd-8fd4-4f84-a307-f270048d503c | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | 2056895 977427 977434 977438 9HW64Q8G6G |
| Artificial Tears | ARTIFICIAL TEARS | AvPAK | f18bebf2-1936-658f-e053-2a95a90a5012 | 2026-07-07 | Warnings | 3NXW29V3WO |
| Everolimus | EVEROLIMUS TABLETS | Breckenridge Pharmaceutical, Inc. | c7bb6ba1-9a7f-43f5-b058-ef26d4b59221 | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 2056895 977427 977434 977438 9HW64Q8G6G |
| EVEROLIMUS | EVEROLIMUS | Biocon Pharma Inc. | 5fb55800-f322-6bb6-9dde-622925ef28bd | 2026-06-30 | Warnings, Adverse reactions | 9HW64Q8G6G |
| Everolimus | EVEROLIMUS | Biocon Pharma Inc. | 5b809dfe-c076-07c5-207e-178c3f0d32d3 | 2026-06-30 | Warnings, Adverse reactions | 9HW64Q8G6G |
| Rohto Sun and Sport | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 8bcc8882-b886-4b55-9bc4-d4b92a41358f | 2026-06-19 | Warnings | 3NXW29V3WO |
| Rohto Dual Light Relief | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 1b597f83-d7f1-cf93-e063-6394a90a99f7 | 2026-06-19 | Warnings | 3NXW29V3WO |
| EVEROLIMUS | EVEROLIMUS | Amneal Pharmaceuticals NY LLC | 6f1ae129-c21e-4c25-84c1-a6757d9a7eb2 | 2026-06-16 | Warnings, Adverse reactions | 9HW64Q8G6G |
| TORPENZ | EVEROLIMUS | Upsher-Smith Laboratories, LLC | 4c0075dd-a0a8-4dc4-be32-1be8383fbbdc | 2026-06-10 | Warnings, Adverse reactions | 9HW64Q8G6G |
| Rohto Digi-Eye | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE | The Mentholatum Company | 5d6f37b9-b568-4cb6-92de-eb40779f3f8c | 2026-06-03 | Warnings | 3NXW29V3WO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.